An update of irbesartan and renin-angiotensin system blockade in diabetic nephropathy

Author： García-Donaire Jose Antonio   Segura Julian   Ruilope Luis Miguel  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.9, 2005-08, pp. : 1587-1596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and Prevention of Diabetic Nephropathy in Caucasian and Asian Patients: The Role of Renin-Angiotensin System Blockade

By Viberti Giancarlo  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 1, 2006-01 ,pp. : 49-55

Adis International

Access to resources Recommend Favorite

The Therapeutic Implications of Renin-Angiotensin System Blockade in Diabetic Retinopathy

By  

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 3, 2011-01 ,pp. : 392-395

Bentham Science Publishers

Access to resources Recommend Favorite

Interaction Between Genetic Polymorphisms in Renin-Angiotensin System (RAS) and Therapeutic Efficacy of RAS Blockade in IgA Nephropathy

By  

Current Pharmacogenomics, Vol. 2, Iss. 2, 2004-06 ,pp. : 157-162

Bentham Science Publishers

Access to resources Recommend Favorite

The Pulmonary Renin-Angiotensin System

By  

Current Pharmaceutical Design, Vol. 9, Iss. 9, 2003-04 ,pp. : 715-722

Bentham Science Publishers

Access to resources Recommend Favorite

Renin-angiotensin System Blockade at the Level of the Angiotensin Converting Enzyme or the Angiotensin Type-1 Receptor: Similarities and Differences

By  

Current Topics in Medicinal Chemistry, Vol. 4, Iss. 4, 2004-01 ,pp. : 473-481

Bentham Science Publishers

Access to resources Recommend Favorite